Literature DB >> 22095397

Dry powder inhaler device influence on carrier particle performance.

Martin J Donovan1, Sin Hyen Kim, Venkatramanan Raman, Hugh D Smyth.   

Abstract

Dry powder inhalers (DPIs) are distinguished from one another by their unique device geometries, reflecting their distinct drug detachment mechanisms, which can be broadly classified into either aerodynamic or mechanical-based detachment forces. Accordingly, powder particles experience different aerodynamic and mechanical forces depending on the inhaler. However, the influence of carrier particle physical properties on the performance of DPIs with different dispersion mechanisms remains largely unexplored. Carrier particle trajectories through two commercial DPIs were modeled with computational fluid dynamics (CFD) and the results were compared with in vitro aerosol studies to assess the role of carrier particle size and shape on inhaler performance. Two percent (w/w) binary blends of budesonide with anhydrous and granulated lactose carriers ranging up to 300 μm were dispersed from both an Aerolizer® and Handihaler® through a cascade impactor at 60 L min(-1). For the simulations, carrier particles were modeled as spherical monodisperse populations with small (32 μm), medium (108 μm), and large (275 μm) particle diameters. CFD simulations revealed the average number of carrier particle-inhaler collisions increased with carrier particle size (2.3-4.0) in the Aerolizer®, reflecting the improved performance observed in vitro. Collisions within the Handihaler®, in contrast, were less frequent and generally independent of carrier particle size. The results demonstrate that the aerodynamic behavior of carrier particles varies markedly with both their physical properties and the inhalation device, significantly influencing the performance of a dry powder inhaler formulation.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22095397     DOI: 10.1002/jps.22824

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  26 in total

1.  Effect of device design on the in vitro performance and comparability for capsule-based dry powder inhalers.

Authors:  Jagdeep Shur; Sau Lee; Wallace Adams; Robert Lionberger; James Tibbatts; Robert Price
Journal:  AAPS J       Date:  2012-06-22       Impact factor: 4.009

2.  Use of Computational Fluid Dynamics (CFD) Dispersion Parameters in the Development of a New DPI Actuated with Low Air Volumes.

Authors:  Worth Longest; Dale Farkas; Karl Bass; Michael Hindle
Journal:  Pharm Res       Date:  2019-05-28       Impact factor: 4.200

3.  Understanding the Different Effects of Inhaler Design on the Aerosol Performance of Drug-Only and Carrier-Based DPI Formulations. Part 1: Grid Structure.

Authors:  Cassandra Ming Shan Leung; Zhenbo Tong; Qi Tony Zhou; John Gar Yan Chan; Patricia Tang; Siping Sun; Runyu Yang; Hak-Kim Chan
Journal:  AAPS J       Date:  2016-05-09       Impact factor: 4.009

Review 4.  In Vitro Testing for Orally Inhaled Products: Developments in Science-Based Regulatory Approaches.

Authors:  Ben Forbes; Per Bäckman; David Christopher; Myrna Dolovich; Bing V Li; Beth Morgan
Journal:  AAPS J       Date:  2015-05-05       Impact factor: 4.009

5.  De-agglomeration Effect of the US Pharmacopeia and Alberta Throats on Carrier-Based Powders in Commercial Inhalation Products.

Authors:  Sharon Shui Yee Leung; Patricia Tang; Qi Tony Zhou; Zhenbo Tong; Cassandra Leung; Janwit Decharaksa; Runyu Yang; Hak-Kim Chan
Journal:  AAPS J       Date:  2015-07-23       Impact factor: 4.009

6.  Effect of device design on the aerosolization of a carrier-based dry powder inhaler--a case study on Aerolizer(®) Foradile (®).

Authors:  Qi Tony Zhou; Zhenbo Tong; Patricia Tang; Mauro Citterio; Runyu Yang; Hak-Kim Chan
Journal:  AAPS J       Date:  2013-02-01       Impact factor: 4.009

7.  The effect of engineered mannitol-lactose mixture on dry powder inhaler performance.

Authors:  Waseem Kaialy; Hassan Larhrib; Gary P Martin; Ali Nokhodchi
Journal:  Pharm Res       Date:  2012-04-05       Impact factor: 4.200

8.  Design, characterization, and aerosol dispersion performance modeling of advanced spray-dried microparticulate/nanoparticulate mannitol powders for targeted pulmonary delivery as dry powder inhalers.

Authors:  Xiaojian Li; Frederick G Vogt; Don Hayes; Heidi M Mansour
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2014-02-06       Impact factor: 2.849

9.  Freeze-dried mannitol for superior pulmonary drug delivery via dry powder inhaler.

Authors:  Waseem Kaialy; Ali Nokhodchi
Journal:  Pharm Res       Date:  2012-10-16       Impact factor: 4.200

10.  Evaluation of granulated lactose as a carrier for DPI formulations 1: effect of granule size.

Authors:  Ping Du; Ju Du; Hugh D C Smyth
Journal:  AAPS PharmSciTech       Date:  2014-06-25       Impact factor: 3.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.